These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32326428)

  • 21. Screening a trace amount of pharmaceutical cocrystals by using an enhanced nano-spot method.
    Tanabe Y; Maeno Y; Ohashi K; Hisada H; Roy A; Carriere J; Heyler R; Fukami T
    Eur J Pharm Biopharm; 2019 Mar; 136():131-137. PubMed ID: 30660695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems.
    Singh M; Barua H; Jyothi VGSS; Dhondale MR; Nambiar AG; Agrawal AK; Kumar P; Shastri NR; Kumar D
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cocrystals of the antibiotic trimethoprim with glutarimide and 3,3-dimethylglutarimide held together by three hydrogen bonds.
    Ton QC; Egert E
    Acta Crystallogr C Struct Chem; 2015 Jan; 71(Pt 1):75-9. PubMed ID: 25567580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications.
    Guo M; Sun X; Chen J; Cai T
    Acta Pharm Sin B; 2021 Aug; 11(8):2537-2564. PubMed ID: 34522597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Lidocaine-Based Pharmaceutical Cocrystals: Preparation, Characterization, and Influence of the Racemic vs. Enantiopure Coformer on the Physico-Chemical Properties.
    Ma P; Toussaint B; Roberti EA; Scornet N; Santos Silva A; Castillo Henríquez L; Cadasse M; Négrier P; Massip S; Dufat H; Hammad K; Baraldi C; Gamberini MC; Richard C; Veesler S; Espeau P; Lee T; Corvis Y
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient Screening of Coformers for Active Pharmaceutical Ingredient Cocrystallization.
    Sugden IJ; Braun DE; Bowskill DH; Adjiman CS; Pantelides CC
    Cryst Growth Des; 2022 Jul; 22(7):4513-4527. PubMed ID: 35915670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Chloro-4-nitrobenzoic acid as a coformer with pharmaceutical cocrystals and molecular salts.
    Lemmerer A
    Acta Crystallogr C Struct Chem; 2020 Aug; 76(Pt 8):746-752. PubMed ID: 32756037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SpeedMixing: Rapid Tribochemical Synthesis and Discovery of Pharmaceutical Cocrystals without Milling or Grinding Media.
    Teoh Y; Ayoub G; Huskić I; Titi HM; Nickels CW; Herrmann B; Friščić T
    Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202206293. PubMed ID: 35894150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diazole-based powdered cocrystal featuring a helical hydrogen-bonded network: structure determination from PXRD, solid-state NMR and computer modeling.
    Sardo M; Santos SM; Babaryk AA; López C; Alkorta I; Elguero J; Claramunt RM; Mafra L
    Solid State Nucl Magn Reson; 2015 Feb; 65():49-63. PubMed ID: 25604487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical Cocrystals of Ethenzamide: Molecular Structure Analysis Based on Vibrational Spectra and DFT Calculations.
    Wan M; Fang J; Xue J; Liu J; Qin J; Hong Z; Li J; Du Y
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational Coformer Selection in the Development of 6-Propyl-2-thiouracil Pharmaceutical Cocrystals.
    Acebedo-Martínez FJ; Alarcón-Payer C; Verdugo-Escamilla C; Martín J; Frontera A; Domínguez-Martín A; Gómez-Morales J; Choquesillo-Lazarte D
    Pharmaceuticals (Basel); 2023 Feb; 16(3):. PubMed ID: 36986470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
    Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
    Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of pharmaceutical cocrystals of 2,6-diaminopyridine with piracetam and theophylline.
    Durán-Palma MH; Mendoza-Barraza SS; Magaña-Vergara NE; Martínez-Martínez FJ; González-González JS
    Acta Crystallogr C Struct Chem; 2017 Oct; 73(Pt 10):767-772. PubMed ID: 28978781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uracil Derivatives for Halogen-Bonded Cocrystals.
    Benito M; Roselló Y; Barceló-Oliver M; Frontera A; Molins E
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Situ Cocrystallization of Dapsone and Caffeine during Fluidized Bed Granulation Processing.
    Todaro V; Worku ZA; Cabral LM; Healy AM
    AAPS PharmSciTech; 2019 Jan; 20(1):28. PubMed ID: 30603811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization.
    Bruni G; Maggi L; Mustarelli P; Sakaj M; Friuli V; Ferrara C; Berbenni V; Girella A; Milanese C; Marini A
    J Pharm Sci; 2019 Apr; 108(4):1529-1539. PubMed ID: 30476510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of Ciprofloxacin-Isonicotinic Acid Cocrystal Using Mechanochemical Synthesis Routes-An Investigation into Critical Process Parameters.
    Karimi-Jafari M; Ziaee A; O'Reilly E; Croker D; Walker G
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
    Boksa K; Otte A; Pinal R
    J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supramolecular hydrogen-bonding patterns in two cocrystals of the N(7)-H tautomeric form of N(6)-benzoyladenine: N(6)-benzoyladenine-3-hydroxypyridinium-2-carboxylate (1/1) and N(6)-benzoyladenine-DL-tartaric acid (1/1).
    Karthikeyan A; Swinton Darious R; Thomas Muthiah P; Perdih F
    Acta Crystallogr C Struct Chem; 2015 Nov; 71(Pt 11):985-90. PubMed ID: 26524172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphs and polymorphic cocrystals of temozolomide.
    Babu NJ; Reddy LS; Aitipamula S; Nangia A
    Chem Asian J; 2008 Jul; 3(7):1122-33. PubMed ID: 18512823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.